Ozempic. WeGovy. Zepbound. Oh My!- Understanding GLP-1 Agonists with Dr. Bhatt and Dr. Goins
Update: 2024-08-08
Description
In this episode of the HVC Podcast, we're diving deep into the world of GLP-1 agonists with two experts in the field, Dr. Bhatt and Dr. Goins. These groundbreaking medications—Ozempic, WeGovy, and the newly introduced Zepbound—are making waves in the treatment of type 2 diabetes and obesity. But how do they work, and what sets them apart from other treatments? Join us as we discuss the benefits and considerations of these medicines.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
